Toronto, Ontario, December 11, 2013 - Polydex Pharmaceuticals Limited (Pink/OTCBB:POLXF) has published its third quarter financial report, and is pleased to announce another profitable quarter this fiscal year as a result of continued high demand from customers and increased, Toronto, Ontario, September 16, 2013 - Polydex Pharmaceuticals Limited (OTC Pink:POLXF) (the "Company") reports that it has continued to experience high demand for product from its customers, resulting in increasing sales and collaborated investments, Toronto, Ontario, July 30, 2013 - Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the "Company") is please to annouce that through it's wholly owned subsidary it has received $250,000 for issuing a new exclusive 10-year supply agreement. Chloramphenicol is an antibiotic which stops bacterial growth in the eye/ear by preventing the synthesis of essential proteins required by the bacteria to carry out vital functions. The Company strives to maintain the highest standards of accuracy, completeness and disclosure in its financial dealings, records and reports. Companies House Companies House does not verify the accuracy of the information filed (link opens a new window) Sign in / Register . You can visit our contact page and submit your inquiry, or e-mail us directly at [email protected] 21. 15. Toronto, Ontario, September 15, 2015 – Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) today announced financial results for the second quarter of fiscal 2016. Toronto, Ontario, March 1st, 2016 – Polydex Pharmaceuticals Limited (OTC/Pink:POLXF)(the “Company”) announces that due to the continuing improvement of operations, its wholly owned subsidiary, Dextran Products Limited, has secured traditional bank financing to replace the existing private mortgage at a lower rate, and has also secured... Polydex Files OTC Market Disclosure Documents. Comply with applicable rules and regulations of federal, state and local governments and other appropriate private and public regulatory agencies. A former Adjunct Professor at York University, Prof. Derek John Michael Lederer is a practicing Chartered Accountant in Toronto, Ontario, Canada. Customer interest continues to grow as reflected in our strong order book. Achieve responsible use of and control over all assets and resources employed or entrusted to him or her. Sri Lanka. All figures are reported in U.S. dollars. Toronto, Ontario, September 16, 2019 – Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the second  quarter of fiscal 2020, the period ending July 31, 2019.

Continued Strong Sales & Increased Gross Profit. Dexamethasone is a steroid. ​Shares Issued & Outstanding  -  3,425,978, Increase in Sales Keeps Company Profitable, Linda C. Hughes Toronto, Ontario, September 14, 2018 – Polydex Pharmaceuticals Limited. Toronto, Ontario, June 17, 2019  – Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the first quarter of fiscal 2020, the period ending April 30, 2019. Toronto, Ontario, June 10, 2014 – Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2015, the period ending April 30, 2014. Sales remain strong, and continued attention to cost control leads to increased gross profit... Polydex President & CEO George Usher to participate at Water Innovation in Action Conference, Waste Water Sysytems Implemented at Dextran Products, To be Focus of Session: Cross-Pollinating to Solve Water Challenges.